Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Definition of low-risk WNT-pathway medulloblastoma may need to be refined, say experts

A new research perspective was published in Oncotarget's Volume 14 on February 7, 2023, entitled, "WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?"

27 Feb 2023

Researchers explore potential new target for cancer immunotherapy

A new study posted to the bioRxiv* preprint server, focused on the role of YAP in regulating MHC-I APM expression within tumor cells.

27 Feb 2023

Viable treatment option for patients with advanced cervical cancer

A recent University of Kentucky Markey Cancer Center study suggests a new radiopharmaceutical compound may be a viable treatment option for patients with advanced cervical cancer.

25 Feb 2023

Novel microfluidic model mimics a rare genetic disorder

Our bodies are made up of 60,000 miles of complex pipes that play a vital role in transporting nutrients throughout our bodies, performing waste disposal, and supplying our organs with fresh oxygen and blood.

24 Feb 2023

Difference between human and mouse lung tumor cells explains the discrepancy in cancer drug results

A small but significant metabolic difference between human and mouse lung tumor cells, has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results, and pointing toward new strategies for developing cancer treatments.

24 Feb 2023

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

A decade-long international study into kidney cancer has shown that doctors can predict the likelihood of a patient's disease returning by looking at DNA mutations in their tumors.

24 Feb 2023

Study: Millions of Americans continued to miss cancer screening tests during the second year of pandemic

According to a new, nationwide study led by researchers at the American Cancer Society (ACS), millions of people in the United States continued to miss critical cancer screening tests during the second year of the COVID-19 pandemic.

23 Feb 2023

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.

23 Feb 2023

Novel fatty liver organoid models could aid in drug discovery and testing

Researchers from the Organoid group (former Clevers group, Hubrecht Institute) together with researchers from the Princess Máxima Center for pediatric oncology established novel human organoid models of fatty liver disease.

23 Feb 2023

UTA professor leads a CPRIT-funded study to better craft a personalized cancer immunotherapy

A University of Texas at Arlington bioengineering professor is leading a state-funded project that will try to identify what T-cells are detecting in cancerous cells to better craft a personalized cancer immunotherapy.

23 Feb 2023

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use.

22 Feb 2023

Monitoring the presence of bovine meat and milk factor protein expression may help identify people at risk of colorectal cancer

Bovine meat and milk factors (BMMFs) - initially identified by de Villiers et al. in 2014 - represent a class of infectious agents in beef and cow's milk that have been linked to the development of cancer.

22 Feb 2023

When cancer research turns to the immune system – the critical role of peptides and immunopeptidomics

In this interview, AZoM speaks to Rohan Thakur, the President of Life Science Mass Spectrometry at Bruker, about what the opportunities of the market are and how Bruker is planning on rising to the challenge.

From Bruker Daltonics 22 Feb 2023

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

To create the most effective, personalized treatment plans for patients with Hodgkin lymphoma or other cancers, scientists and clinicians need the clearest picture of the genetic changes leading to the cancer's development.

21 Feb 2023

Medicaid expansion may improve outcomes for children with cancer

Medicaid expansion may improve outcomes for children with cancer, finds a new analysis from the Brown School and Washington University School of Medicine in St. Louis.

21 Feb 2023

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Patients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to have more-aggressive tumors and significantly lower overall survival (OS) than those in higher-income neighborhoods, according to research led by Roswell Park Comprehensive Cancer Center.

21 Feb 2023

Life Sciences Innovator Category Winner 2023

Following a rigorous application process, we are proud to announce that Seda have been selected as the UK Life Sciences Innovator Winner 2023 in the Application, Product & Service Design Category.

From Seda Pharmaceutical Development Services 21 Feb 2023

Healthful eating plan and regular physical activity can help reduce cancer risk

Cancer is the second leading cause of death in the United States, behind heart disease. While no cancer is 100% preventable, a healthful eating plan and regular physical activity can help reduce your risk of developing cancer, according to the Academy of Nutrition and Dietetics.

21 Feb 2023

“Cell food” reveals how different metabolic programs regulate T cell persistence

New research from the University of Michigan Rogel Cancer Center reveals that the metabolic pathways that make a specific type of T cell function are different than previously believed.

17 Feb 2023

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Patients with resectable non-small cell lung cancer (NSCLC) who were treated with neoadjuvant nivolumab had improved five-year recurrence-free and overall survival rates compared with historical outcomes.

15 Feb 2023

Oncology News and Research

Further Reading

Definition of low-risk WNT-pathway medulloblastoma may need to be refined, say experts

Researchers explore potential new target for cancer immunotherapy

Viable treatment option for patients with advanced cervical cancer

Novel microfluidic model mimics a rare genetic disorder

Difference between human and mouse lung tumor cells explains the discrepancy in cancer drug results

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

Study: Millions of Americans continued to miss cancer screening tests during the second year of pandemic

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

Novel fatty liver organoid models could aid in drug discovery and testing

UTA professor leads a CPRIT-funded study to better craft a personalized cancer immunotherapy

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Monitoring the presence of bovine meat and milk factor protein expression may help identify people at risk of colorectal cancer

When cancer research turns to the immune system – the critical role of peptides and immunopeptidomics

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

Medicaid expansion may improve outcomes for children with cancer

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Life Sciences Innovator Category Winner 2023

Healthful eating plan and regular physical activity can help reduce cancer risk

“Cell food” reveals how different metabolic programs regulate T cell persistence

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News